The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene label mismatch: APC vs undefined
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000038.6(APC):c.933G>C (p.Lys311Asn)

CA16023349

1025291 (ClinVar)

Gene: APC (HGNC:324)
Condition: familial adenomatous polyposis 1 (MONDO:0021056)
Inheritance Mode: Autosomal dominant inheritance
UUID: 25c5fc2f-b417-4d43-a9cb-4a31806c7e0c
Approved on: 2025-05-16
Published on: 2025-05-16

HGVS expressions

NM_000038.6:c.933G>C
NM_000038.6(APC):c.933G>C (p.Lys311Asn)
NC_000005.10:g.112815593G>C
CM000667.2:g.112815593G>C
NC_000005.9:g.112151290G>C
CM000667.1:g.112151290G>C
NC_000005.8:g.112179189G>C
NG_008481.4:g.128073G>C
ENST00000502371.3:c.933G>C
ENST00000504915.3:c.933G>C
ENST00000505084.2:n.989G>C
ENST00000505350.2:c.*939G>C
ENST00000507379.6:c.879G>C
ENST00000509732.6:c.933G>C
ENST00000512211.7:c.933G>C
ENST00000257430.9:c.933G>C
ENST00000257430.8:c.933G>C
ENST00000507379.5:c.879G>C
ENST00000508376.6:c.933G>C
ENST00000508624.5:c.*255G>C
ENST00000512211.6:c.933G>C
NM_000038.5:c.933G>C
NM_001127510.2:c.933G>C
NM_001127511.2:c.879G>C
NM_001354895.1:c.933G>C
NM_001354896.1:c.933G>C
NM_001354897.1:c.963G>C
NM_001354898.1:c.858G>C
NM_001354899.1:c.849G>C
NM_001354900.1:c.756G>C
NM_001354901.1:c.756G>C
NM_001354902.1:c.963G>C
NM_001354903.1:c.933G>C
NM_001354904.1:c.858G>C
NM_001354905.1:c.756G>C
NM_001354906.1:c.84G>C
NM_001127510.3:c.933G>C
NM_001127511.3:c.879G>C
NM_001354895.2:c.933G>C
NM_001354896.2:c.933G>C
NM_001354897.2:c.963G>C
NM_001354898.2:c.858G>C
NM_001354899.2:c.849G>C
NM_001354900.2:c.756G>C
NM_001354901.2:c.756G>C
NM_001354902.2:c.963G>C
NM_001354903.2:c.933G>C
NM_001354904.2:c.858G>C
NM_001354905.2:c.756G>C
NM_001354906.2:c.84G>C
More

Likely Pathogenic

Met criteria codes 3
PS4_Supporting PM2_Supporting PVS1_Strong

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for APC Version 2.1.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
InSiGHT Hereditary Colorectal Cancer/Polyposis VCEP
The NM_000038.6(APC):c.933G>C variant in APC is a G to non-G change at the last nucleotide of exon 9. RNA analysis demonstrated that the variant impacts splicing by an insertion of the first 66 nucleotides of intron 9, resulting in a premature stop codon (r.933_934ins933+1_933+66 p.K311_V312insVTEDYKPWSLMP*) (internal data Ambry Genetics; in Fig. 1B of the ACMG/AMP criteria specification by the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis VCEP [HCCP VCEP] the variant was evaluated as PVS1_Supporting, but based on the additional RNA data the HCCP VCEP considers PVS1_Strong as applicable for this variant). This variant has been reported in 2 probands meeting phenotypic criteria, resulting in a total phenotype score of 1.5 (PS4_Supporting, PMID: 20685668, internal data Labcorp Genetics [formerly Invitae]). This variant is absent in gnomAD v2.1.1 (PM2_Supporting). In summary, this variant meets the criteria to be classified as Likely Pathogenic for autosomal-dominant inherited FAP based on the ACMG/AMP criteria applied, as specified by the HCCP VCEP: PVS1_Strong, PS4_Supporting, PM2_Supporting applied (VCEP specifications version v2.0.3; date of approval 7/24/2023).
Met criteria codes
PS4_Supporting
This variant has been reported in 2 probands meeting phenotypic criteria, resulting in a total phenotype score of 1.5 (PS4_Supporting, PMID: 20685668, internal data Labcorp Genetics [formerly Invitae]).
PM2_Supporting
This variant is absent in gnomAD v2.1.1 (PM2_Supporting).
PVS1_Strong
RNA analysis demonstrated that the variant impacts splicing by an insertion of the first 66 nucleotides of intron 9, resulting in a premature stop codon (r.933_934ins933+1_933+66 p.K311_V312insVTEDYKPWSLMP*) (internal data Ambry Genetics; in Fig. 1B of the ACMG/AMP criteria specification by the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis VCEP [HCCP VCEP] the variant was evaluated as PVS1_Supporting, but based on the additional RNA data the HCCP VCEP considers PVS1_Strong as applicable for this variant).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.